Subsequently, we displayed subgroup analyses of prognosis, which indicated that elevated PROS1 expression was correlated with poor overall survival in glioma patients with PR &CR,1p/19q non-codel, astrocytoma, and WHO G2&G3 grade (Figures 8E, F). This evidence concerns the gene PROS1 and glioma.